Related references
Note: Only part of the references are listed.Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth
Peter C. Ray et al.
ACS OMEGA (2021)
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Francesca Conradie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis
Qinglan Wang et al.
SCIENCE (2020)
Biological Profiling Enables Rapid Mechanistic Classification of Phenotypic Screening Hits and Identification of KatG Activation-Dependent Pyridine Carboxamide Prodrugs With Activity Against Mycobacterium tuberculosis
Melissa D. Chengalroyen et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Opposing reactions in coenzyme A metabolism sensitize Mycobacterium tuberculosis to enzyme inhibition
Elaine Ballinger et al.
SCIENCE (2019)
Novel MenA Inhibitors Are Bactericidal against Mycobacterium tuberculosis and Synergize with Electron Transport Chain Inhibitors
Bryan J. Berube et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Tuberculosis drugs' distribution and emergence of resistance in patient's lung lesions: A mechanistic model and tool for regimen and dose optimization
Natasha Strydom et al.
PLOS MEDICINE (2019)
Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline
Zhe Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development
Tiago Beites et al.
NATURE COMMUNICATIONS (2019)
Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis
Julie Early et al.
ACS INFECTIOUS DISEASES (2019)
Anthranilic amide and imidazobenzothiadiazole compounds disrupt Mycobacterium tuberculosis membrane potential
Jake Smith et al.
MEDCHEMCOMM (2019)
Targeting protein biotinylation enhances tuberculosis chemotherapy
Divya Tiwari et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
High-resolution mapping of fluoroquinolones in TB rabbit lesions reveals specific distribution in immune cell types
Landry Blanc et al.
ELIFE (2018)
Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis
Yumi Park et al.
ACS INFECTIOUS DISEASES (2017)
Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
Murat Cokol et al.
SCIENCE ADVANCES (2017)
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13
Anup Aggarwal et al.
CELL (2017)
Contribution of Oxazolidinones to the Efficacy of Novel Regimens Containing Bedaquiline and Pretomanid in a Mouse Model of Tuberculosis
Rokeya Tasneen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Inflammatory signaling in human tuberculosis granulomas is spatially organized
Mohlopheni J. Marakalala et al.
NATURE MEDICINE (2016)
β-Lactams against Tuberculosis - New Trick for an Old Dog?
Andreas H. Diacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis
Joanna C. Evans et al.
ACS INFECTIOUS DISEASES (2016)
Prediction of Drug Penetration in Tuberculosis Lesions
Jansy P. Sarathy et al.
ACS INFECTIOUS DISEASES (2016)
The association between sterilizing activity and drug distribution into tuberculosis lesions
Brendan Prideaux et al.
NATURE MEDICINE (2015)
Novel Inhibitors of Cholesterol Degradation in Mycobacterium tuberculosis Reveal How the Bacterium's Metabolism Is Constrained by the Intracellular Environment
Brian C. VanderVen et al.
PLOS PATHOGENS (2015)
Host-Mediated Bioactivation of Pyrazinamide: Implications for Efficacy, Resistance, and Therapeutic Alternatives
Laura E. Via et al.
ACS INFECTIOUS DISEASES (2015)
Identification of Novel Anti-rnycobacterial Compounds by Screening a Pharmaceutical Small-Molecule Library against Nonreplicating Mycobacterium tuberculosis
Thulasi Warrier et al.
ACS INFECTIOUS DISEASES (2015)
Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
Lluis Ballell et al.
CHEMMEDCHEM (2013)
A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence
Jee-Hyun Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Para-Aminosalicylic Acid Acts as an Alternative Substrate of Folate Metabolism in Mycobacterium tuberculosis
Sumit Chakraborty et al.
SCIENCE (2013)
Share Paper
